<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220424054639N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-06-13</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The Effect Of Oral Capsules Of Jujube Fruit Extract On The Prevention Of Postpartum Depression</public_title>
      <acronym></acronym>
      <scientific_title>The Effect Of Oral Capsules Of Jujube Fruit Extract On The Prevention Of Postpartum Depression</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>128</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63358</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: This Study Will Be Performed As A Three-Blind Randomized Controlled Clinical Trial. The Research Environment Is Torbate Jam Health Center And All Comprehensive Urban Health Service Centers (All Four Urban Service Centers) Under The Auspices Of This Center Will Be Selected As The Research Community. Sampling Is Done In A Class Of 4 Comprehensive Urban Health Service Centers And Then Random Allocation (The Method Of Allocating People To Two Groups Will Be Random And Using The Method Of 4 Blocks). The Randomization Tool Will Be A Table Of Random Numbers, Blinding description: In This Study, Both Participants And Researchers Or Outcome Assessors Are Unaware Of The Allocation Of Study Groups.</study_design>
      <phase>3</phase>
      <hc_freetext>Postpartum depression.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Includes An Intervention Group That In Addition To Receiving Routine Care Performed By Midwives Working In Comprehensive Health Service Centers On Days 1-3, 10-15, 30-42 After Delivery, Recipient Of Oral Capsules Of Jujube Fruit Extract From The Tenth Day Are After Childbirth. Mothers In This Group Will Receive 1200 Mg Of Jujube Fruit Capsules Daily Along With 300 Mg Of Excipients Including Avisel In The Form Of Two 750 Capsules Twice A Day For Half An Hour After Breakfast And Dinner For Six Weeks And A Depression Questionnaire. After Giving Birth To Edinburgh, This Group Will Be Completed At The End Of The Second, Fourth And Sixth Weeks After Entering The Study. Inform The Researcher Of Any Allergies, Problems Or Any Side Effects Through The Contact Number Provided To Them. Intervention 2: Control group: Includes A Control Group (Receiving Placebo Capsules): In Addition To Receiving Routine Postpartum Care, The Control Group Will Receive A Placebo Capsule Containing 750 Mg Of Oisel Powder Twice Daily After Breakfast And Dinner For 6 Weeks. Routine Postpartum Care Includes Routine Midwifery Care On Days 1-3, 10-15, 30-42 After Delivery By The Midwife. Mental Health Screening In The First, Second And Third Postpartum Care Is Based On The Edinburgh Questionnaire, And If The Evaluation Results Are Positive Based On The Cut-Off Point Of The Questionnaire (Score 12 And Above), The Mother Suffers From Postpartum Depression And Should Be Additional Evaluation Should Be Referred To A Doctor Immediately (At The Earliest Opportunity).Mothers Whose Test Scores Are 12 And Older Suffer From Postpartum Depression. Scores 14 And 15 Are Severe Depression. Women With Some Symptoms Of Depression (No Suicidal Ideation) Or A Score Between 5 And 9 Should Be Re-Evaluated A Month Later. The Edinburgh Postpartum Depression Inventory For This Group Is Completed At The End Of The Second, Fourth And Sixth Weeks After Entering The Study.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Statistical Data And Results Of Statistical Analysis Will Be Shared In The Form Of Tables And Graphs. Some Of The Forms And Questionnaires Used Will Be Shared

When:
Access Period Starts From Six Months After The Results Are Published Until 1 Year Later

To whom:
The Data Will Be Available Only To Researchers Working In Academic And Scientific Institutions

Conditions:
In Order To Use The Data, Only The Responsible Researcher Should Be Contacted And It Will Be Possible To Publish Through Her

Where to obtain:
Applicants Should Contact The Research Officer Via Email
JahaniSHN@mums.ac.ir

How to obtain:
A Data Request And Document Must Be Sent To The Responsible Author In The Form Of A Valid Academic Email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nahid Jahani Shoorab</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Office of Midwifery, First Floor, Professors Building, School of Nursing and Midwifery, Daneshgah St.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>JAHANISHN@MUMS.AC.IR</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nahid Jahani Shoorab</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Office of Midwifery, First Floor, Professors Building, School of Nursing and Midwifery, Ph.D.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>JAHANISHN@MUMS.AC.IR</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Conscious Consent Of The Mother
Women 18-40 Years Old
Recent Pregnancy Asked
No History Of Recurrent Miscarriage Or Infertility
Resident Of Torbate Jam
Live With His Wife
On The 10th Day After Normal Delivery Without Complications (Complication: Any Obstetric Complications Such As High Blood Pressure, Diabetes Or Hospitalization Of The Mother Due To Postpartum Complications)
Having A Low-Risk Pregnancy (Low-Risk Pregnancy: A Pregnancy That Has No Potential Side Effects That Threaten The Health Of The Mother And Fetus)
Having A Mobile Phone Number
No Stress, Depression And Severe Anxiety (Depression And Severe Anxiety: Scores Of 24 And Above On The Stress Subscale And 15 And More On The Anxiety Subscale And 21 And More On The DASS-21 Questionnaire)
Score Less Than 12 On The Edinburgh Depression Test
Do Not Be Allergic To Jujube
No Accidents (Accidents Such As The Death Or Hospitalization Of A Family Member During The Last Three Months)
Do Not Currently Be Treated For Depression
Have No Medical History (Medical Conditions: Hypertension, Hypothyroidism And  Parathyroidism, Heart Disease, Kidney Disease, Hypertension Under Treatment, Migraine, Epilepsy, Respiratory Disease, Hyperlipidemia, Diabetes)
Do Not Have Any Mental Illness (Mental Illness: A History Of Depression Or Neurological Disease Or Any Other Mental Disorder According To The Patient)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Reluctance To Continue Research
Do Not Take The Drug For Two Consecutive Days
Incidence Of Jujube Allergy
Major Stress During Study(Major Stress: Serious Illness Of Yourself Or A Spouse, Death Of A Loved One, Unemployment, Accidents And Severe Family Disputes)
Depression While Studying With A Psychiatrist Diagnosis
The Baby Has An Abnormality Or The Baby Dies
Change Of Residence During The Study
Smoking, Drinking Alcohol Or Taking Any Drugs</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F53</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Puerperal psychosis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Includes An Intervention Group That In Addition To Receiving Routine Care Performed By Midwives Working In Comprehensive Health Service Centers On Days 1-3, 10-15, 30-42 After Delivery, Recipient Of Oral Capsules Of Jujube Fruit Extract From The Tenth Day Are After Childbirth. Mothers In This Group Will Receive 1200 Mg Of Jujube Fruit Capsules Daily Along With 300 Mg Of Excipients Including Avisel In The Form Of Two 750 Capsules Twice A Day For Half An Hour After Breakfast And Dinner For Six Weeks And A Depression Questionnaire. After Giving Birth To Edinburgh, This Group Will Be Completed At The End Of The Second, Fourth And Sixth Weeks After Entering The Study. Inform The Researcher Of Any Allergies, Problems Or Any Side Effects Through The Contact Number Provided To Them.</i_keyword>
      <i_keyword>Control group: Includes A Control Group (Receiving Placebo Capsules): In Addition To Receiving Routine Postpartum Care, The Control Group Will Receive A Placebo Capsule Containing 750 Mg Of Oisel Powder Twice Daily After Breakfast And Dinner For 6 Weeks. Routine Postpartum Care Includes Routine Midwifery Care On Days 1-3, 10-15, 30-42 After Delivery By The Midwife. Mental Health Screening In The First, Second And Third Postpartum Care Is Based On The Edinburgh Questionnaire, And If The Evaluation Results Are Positive Based On The Cut-Off Point Of The Questionnaire (Score 12 And Above), The Mother Suffers From Postpartum Depression And Should Be Additional Evaluation Should Be Referred To A Doctor Immediately (At The Earliest Opportunity).Mothers Whose Test Scores Are 12 And Older Suffer From Postpartum Depression. Scores 14 And 15 Are Severe Depression. Women With Some Symptoms Of Depression (No Suicidal Ideation) Or A Score Between 5 And 9 Should Be Re-Evaluated A Month Later. The Edinburgh Postpartum Depression Inventory For This Group Is Completed At The End Of The Second, Fourth And Sixth Weeks After Entering The Study.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression Score Before And After The Intervention. Timepoint: At The Beginning Of The Study And At The End Of The Second, Fourth And Sixth Weeks After Entering The Study, The Depression Score Will Be Measured. Method of measurement: Edinburgh Postpartum Depression Screening Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Satisfaction With The Sex Of The Baby. Timepoint: At The Beginning Of The Study. Method of measurement: Demographic And Midwifery Profile Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-05-10</approval_date>
        <contact_name>Ethics Committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>No. 63, Motahhari St., Motahhari St., Islamic Republic Square Torbate Jam Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
